Literature DB >> 26564227

A BMD threshold for treatment efficacy in osteoporosis? A need to consider the whole evidence base.

E McCloskey1.   

Abstract

Entities:  

Mesh：

Year:  2015        PMID： 26564227     DOI： 10.1007/s00198-015-3406-5

Source DB:  PubMed          Journal:  Osteoporos Int        ISSN： 0937-941X            Impact factor:   4.507


× No keyword cloud information.
  20 in total

1.  The real enemy is fragility fracture, not osteoporosis.

Authors:  C E Uzoigwe
Journal:  Osteoporos Int       Date:  2015-11-13       Impact factor: 4.507

2.  Clodronate reduces the incidence of fractures in community-dwelling elderly women unselected for osteoporosis: results of a double-blind, placebo-controlled randomized study.

Authors:  Eugene V McCloskey; Monique Beneton; Diane Charlesworth; Karthik Kayan; Dominic deTakats; Abhijit Dey; Jane Orgee; Robert Ashford; Martin Forster; Jennifer Cliffe; Linda Kersh; John Brazier; Jon Nichol; Sakari Aropuu; Tarja Jalava; John A Kanis
Journal:  J Bone Miner Res       Date:  2007-01       Impact factor: 6.741

3.  Fracture risk assessment without bone density measurement in routine clinical practice.

Authors:  W D Leslie; S Morin; L M Lix; H Johansson; A Oden; E McCloskey; J A Kanis
Journal:  Osteoporos Int       Date:  2011-08-18       Impact factor: 4.507

4.  Risedronate decreases fracture risk in patients selected solely on the basis of prior vertebral fracture.

Authors:  J A Kanis; I P Barton; O Johnell
Journal:  Osteoporos Int       Date:  2004-07-23       Impact factor: 4.507

5.  Effects of estrogen plus progestin on risk of fracture and bone mineral density: the Women's Health Initiative randomized trial.

Authors:  Jane A Cauley; John Robbins; Zhao Chen; Steven R Cummings; Rebecca D Jackson; Andrea Z LaCroix; Meryl LeBoff; Cora E Lewis; Joan McGowan; Joan Neuner; Mary Pettinger; Marcia L Stefanick; Jean Wactawski-Wende; Nelson B Watts
Journal:  JAMA       Date:  2003-10-01       Impact factor: 56.272

6.  Optimization of BMD measurements to identify high risk groups for treatment--a test analysis.

Authors:  Helena Johansson; Anders Oden; Olof Johnell; Bengt Jonsson; Chris de Laet; Alan Oglesby; Eugene V McCloskey; Karthik Kayan; Tarja Jalava; John A Kanis
Journal:  J Bone Miner Res       Date:  2004-06       Impact factor: 6.741

7.  Efficacy and safety of a once-yearly intravenous zoledronic acid 5 mg for fracture prevention in elderly postmenopausal women with osteoporosis aged 75 and older.

Authors:  Steven Boonen; Dennis M Black; Cathleen S Colón-Emeric; Richard Eastell; Jay S Magaziner; Erik Fink Eriksen; Peter Mesenbrink; Patrick Haentjens; Kenneth W Lyles
Journal:  J Am Geriatr Soc       Date:  2010-01-08       Impact factor: 5.562

8.  Clodronate reduces vertebral fracture risk in women with postmenopausal or secondary osteoporosis: results of a double-blind, placebo-controlled 3-year study.

Authors:  Eugene McCloskey; Peter Selby; Mike Davies; John Robinson; Roger M Francis; Judith Adams; Karthik Kayan; Monique Beneton; Tarja Jalava; Liisa Pylkkänen; Juha Kenraali; Sakari Aropuu; John A Kanis
Journal:  J Bone Miner Res       Date:  2004-01-19       Impact factor: 6.741

9.  Overdiagnosis of bone fragility in the quest to prevent hip fracture.

Authors:  Teppo L N Järvinen; Karl Michaëlsson; Jarkko Jokihaara; Gary S Collins; Thomas L Perry; Barbara Mintzes; Vijaya Musini; Juan Erviti; Javier Gorricho; James M Wright; Harri Sievänen
Journal:  BMJ       Date:  2015-05-26

10.  Assessing the impact of osteoporosis on the burden of hip fractures.

Authors:  Anders Odén; Eugene V McCloskey; Helena Johansson; John A Kanis
Journal:  Calcif Tissue Int       Date:  2012-11-08       Impact factor: 4.333
View more
  7 in total

1.  Postmenopausal Osteoporosis.

Authors:  Karl Michaëlsson; Per Aspenberg
Journal:  N Engl J Med       Date:  2016-05-26       Impact factor: 91.245

2.  Is it time to consider population screening for fracture risk in postmenopausal women? A position paper from the International Osteoporosis Foundation Epidemiology/Quality of Life Working Group.

Authors:  P Chotiyarnwong; E V McCloskey; N C Harvey; M Lorentzon; D Prieto-Alhambra; B Abrahamsen; J D Adachi; F Borgström; O Bruyere; J J Carey; P Clark; C Cooper; E M Curtis; E Dennison; M Diaz-Curiel; H P Dimai; D Grigorie; M Hiligsmann; P Khashayar; E M Lewiecki; P Lips; R S Lorenc; S Ortolani; A Papaioannou; S Silverman; M Sosa; P Szulc; K A Ward; N Yoshimura; J A Kanis
Journal:  Arch Osteoporos       Date:  2022-06-28       Impact factor: 2.879

Review 3.  UK clinical guideline for the prevention and treatment of osteoporosis.

Authors:  Celia L Gregson; David J Armstrong; Jean Bowden; Cyrus Cooper; John Edwards; Neil J L Gittoes; Nicholas Harvey; John Kanis; Sarah Leyland; Rebecca Low; Eugene McCloskey; Katie Moss; Jane Parker; Zoe Paskins; Kenneth Poole; David M Reid; Mike Stone; Julia Thomson; Nic Vine; Juliet Compston
Journal:  Arch Osteoporos       Date:  2022-04-05       Impact factor: 2.879

4.  UK clinical guideline for the prevention and treatment of osteoporosis.

Authors:  J Compston; A Cooper; C Cooper; N Gittoes; C Gregson; N Harvey; S Hope; J A Kanis; E V McCloskey; K E S Poole; D M Reid; P Selby; F Thompson; A Thurston; N Vine
Journal:  Arch Osteoporos       Date:  2017-04-19       Impact factor: 2.617

Review 5.  Review of the guideline of the American College of Physicians on the treatment of osteoporosis.

Authors:  J A Kanis; C Cooper; R Rizzoli; J-Y Reginster
Journal:  Osteoporos Int       Date:  2018-06-04       Impact factor: 4.507

6.  FRAX-Based Intervention Thresholds for Osteoporosis Treatment in Ukraine.

Authors:  Vladyslav Povoroznyuk; Nataliia Grygorieva; Helena Johansson; Mattias Lorentzon; Nicholas C Harvey; Eugene V McCloskey; Anna Musienko; Enwu Liu; John A Kanis; Nataliia Zaverukha; Oksana Ivanyk
Journal:  J Osteoporos       Date:  2021-06-10

7.  Management of Patients With High Baseline Hip Fracture Risk by FRAX Reduces Hip Fractures-A Post Hoc Analysis of the SCOOP Study.

Authors:  Eugene McCloskey; Helena Johansson; Nicholas C Harvey; Lee Shepstone; Elizabeth Lenaghan; Ric Fordham; Ian Harvey; Amanda Howe; Cyrus Cooper; Shane Clarke; Neil Gittoes; Alison Heawood; Richard Holland; Tarnya Marshall; Terence W O'Neill; Tim J Peters; Niamh Redmond; David Torgerson; John A Kanis
Journal:  J Bone Miner Res       Date:  2018-03-23       Impact factor: 6.741
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.